Severe Bone and Muscle Pain with Bisphosphonates


A recent FDA article describes severe pain associated with two bisphosphonate drugs: Fosamax (alendronate sodium) and Actonel (risedronate sodium).The article, which was published in the Archives of Internal Medicine, describes over a hundred reports received by the FDA of severe bone, joint and muscle pain in patients being treated with Fosamax for osteoporosis. Many patients were unable to walk, climb stairs, or perform usual activities, and some of them became bedridden. Many of them had numerous diagnostic tests with mostly normal findings.

A majority of the patients experienced relief from pain after the drug was discontinued. This improvement was gradual in most of the patients, although some did show immediate improvement.

Thearticle also notes that the FDA has received similar reports for Actonel, another bisphosphonate drug, and this suggests a possible class effect for these drugs.

The article says that pain in patients treated with bisphosphonates is likely to be underreported because of its subjective nature andbecause physicians may attribute the pain to the osteoporosis itself. It concludes that patients should be instructed to report severe bone, joint, or muscle pain that starts shortly after beginning bisphosphonate therapy, and that physicians should consider discontinuing the drug if that happens.







Channel: News
Uploaded: June 11, 2008 at 6:13 pm
Author: LawsuitGuru

Length: 00:01:39
Rating:
Views: 289

Tags: Actonel Drug Safety Bisphoshonates FDA Bone Reaction Fosamax Osteoporosis Muscle Pain Patient

Embed Code:


Video Comments:
No Comment
 

Privacy Policy Cancer Video | Treatment Survival & Education Copyright © 2007 All Rights Reserved.